skip to main content
Idioma:
Refinado por: assunto: Aged remover assunto: Carcinoma, Non-Small-Cell Lung - Mortality remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Gandhi, Leena ; Rodríguez-Abreu, Delvys ; Gadgeel, Shirish ; Esteban, Emilio ; Felip, Enriqueta ; De Angelis, Flávia ; Domine, Manuel ; Clingan, Philip ; Hochmair, Maximilian J ; Powell, Steven F ; Cheng, Susanna Y.-S ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Hui, Rina ; Garon, Edward B ; Boyer, Michael ; Rubio-Viqueira, Belén ; Novello, Silvia ; Kurata, Takayasu ; Gray, Jhanelle E ; Vida, John ; Wei, Ziwen ; Yang, Jing ; Raftopoulos, Harry ; Pietanza, M. Catherine ; Garassino, Marina C

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Kurata, Takayasu ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Faivre-Finn, Corinne ; Reck, Martin ; Vansteenkiste, Johan ; Spigel, David R ; Wadsworth, Catherine ; Melillo, Giovanni ; Taboada, Maria ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

Gadgeel, Shirish ; Rodríguez-Abreu, Delvys ; Speranza, Giovanna ; Esteban, Emilio ; Felip, Enriqueta ; Dómine, Manuel ; Hui, Rina ; Hochmair, Maximilian J ; Clingan, Philip ; Powell, Steven F ; Cheng, Susanna Yee-Shan ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Garon, Edward B ; Novello, Silvia ; Rubio-Viqueira, Belén ; Boyer, Michael ; Kurata, Takayasu ; Gray, Jhanelle E ; Yang, Jing ; Bas, Tuba ; Pietanza, M Catherine ; Garassino, Marina C

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1505-1517 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Reck, Martin ; Rodríguez-Abreu, Delvys ; Robinson, Andrew G ; Hui, Rina ; Csőszi, Tibor ; Fülöp, Andrea ; Gottfried, Maya ; Peled, Nir ; Tafreshi, Ali ; Cuffe, Sinead ; O’Brien, Mary ; Rao, Suman ; Hotta, Katsuyuki ; Leiby, Melanie A ; Lubiniecki, Gregory M ; Shentu, Yue ; Rangwala, Reshma ; Brahmer, Julie R

The New England journal of medicine, 2016-11, Vol.375 (19), p.1823-1833 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Yokoi, Takashi ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Wadsworth, Catherine ; Melillo, Giovanni ; Jiang, Haiyi ; Huang, Yifan ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
6
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Barlesi, F. ; Scherpereel, A. ; Gorbunova, V. ; Gervais, R. ; Vikström, A. ; Chouaid, C. ; Chella, A. ; Kim, J.H. ; Ahn, M.J. ; Reck, M. ; Pazzola, A. ; Kim, H.T. ; Aerts, J.G ; Morando, C. ; Loundou, A. ; Groen, H.J.M. ; Rittmeyer, A.

Annals of oncology, 2014-05, Vol.25 (5), p.1044-1052 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Brahmer, Julie R ; Rodríguez-Abreu, Delvys ; Robinson, Andrew G ; Hui, Rina ; Csőszi, Tibor ; Fülöp, Andrea ; Gottfried, Maya ; Peled, Nir ; Tafreshi, Ali ; Cuffe, Sinead ; O'Brien, Mary ; Rao, Suman ; Hotta, Katsuyuki ; Zhang, Jin ; Lubiniecki, Gregory M ; Deitz, Anne C ; Rangwala, Reshma ; Reck, Martin

The lancet oncology, 2017-12, Vol.18 (12), p.1600-1609 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Brahmer, Julie ; Reckamp, Karen L ; Baas, Paul ; Crinò, Lucio ; Eberhardt, Wilfried E.E ; Poddubskaya, Elena ; Antonia, Scott ; Pluzanski, Adam ; Vokes, Everett E ; Holgado, Esther ; Waterhouse, David ; Ready, Neal ; Gainor, Justin ; Arén Frontera, Osvaldo ; Havel, Libor ; Steins, Martin ; Garassino, Marina C ; Aerts, Joachim G ; Domine, Manuel ; Paz-Ares, Luis ; Reck, Martin ; Baudelet, Christine ; Harbison, Christopher T ; Lestini, Brian ; Spigel, David R

The New England journal of medicine, 2015-07, Vol.373 (2), p.123-135 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Paz-Ares, Luis, Dr ; Mezger, Jörg, Prof ; Ciuleanu, Tudor E, Prof ; Fischer, Jürgen R, MD ; von Pawel, Joachim, MD ; Provencio, Mariano, Prof ; Kazarnowicz, Andrzej, MD ; Losonczy, György, Prof ; de Castro, Gilberto, MD ; Szczesna, Aleksandra, MD ; Crino, Lucio, MD ; Reck, Martin, MD ; Ramlau, Rodryg, Prof ; Ulsperger, Ernst, MD ; Schumann, Christian, MD ; Miziara, Jose Elias A, MD ; Lessa, Álvaro E, MD ; Dediu, Mircea, MD ; Bálint, Beatrix, PhD ; Depenbrock, Henrik, MD ; Soldatenkova, Victoria, MSc ; Kurek, Raffael, MD ; Hirsch, Fred R, Prof ; Thatcher, Nick, FRCP ; Socinski, Mark A, Prof

The lancet oncology, 2015-03, Vol.16 (3), p.328-337 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer

Rosell, R. ; Robinet, G. ; Szczesna, A. ; Ramlau, R. ; Constenla, M. ; Mennecier, B. C. ; Pfeifer, W. ; O'Byrne, K. J. ; Welte, T. ; Kolb, R. ; Pirker, R. ; Chemaissani, A. ; Perol, M. ; Ranson, M. R. ; Ellis, P. A. ; Pilz, K. ; Reck, M.

Annals of oncology, 2008-02, Vol.19 (2), p.362-369 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2007  (2)
  2. 2007Até2009  (3)
  3. 2010Até2014  (4)
  4. 2015Até2017  (6)
  5. Após 2017  (3)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (16)
  2. Japonês  (3)
  3. Russo  (1)
  4. Alemão  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.